GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Profound Medical Corp.
Profound Medical develops minimally invasive ultrasound-based treatments for prostate cancer. Its stock price reflects the pace of adoption of this technology by urologists and the receipt of reimbursements from insurance companies.
Share prices of companies in the market segment - Therapeutic medical equipment
Profound Medical develops and commercializes focused ultrasound-based therapeutic devices for the minimally invasive treatment of prostate cancer and tremors. We classify it as "Therapeutic Medical Equipment." The chart below illustrates the dynamics of this innovative medical sector.
Broad Market Index - GURU.Markets
Profound Medical is a medical company that developed TULSA-PRO technology for minimally invasive ultrasound-based prostate cancer treatment. Its innovativeness earned it a spot in the GURU.Markets index. The chart below compares its performance with the market.
Change in the price of a company, segment, and market as a whole per day
PROF - Daily change in the company's share price Profound Medical Corp.
For Profound Medical Corp., daily price volatility reflects sensitivity to news about the approval and implementation of its medical technologies. This metric is an important component in formulas that assess the risks and potential of companies in the innovative medical device sector.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Profound Medical Corp. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to PROF, which focuses on prostate cancer treatment, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Profound Medical develops medical devices for non-invasive treatment of diseases. It is an innovative medtech company whose stock price responds to clinical successes and regulatory decisions. Its history reflects the medtech sector's contribution to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Profound Medical Corp.
For Profound Medical Corp., the year-over-year trend is a story of the adoption of its technology for non-invasive prostate cancer treatment. Its market capitalization growth over the past 12 months reflects the growing number of hospitals using its TULSA-PRO system, which enables MRI-guided ultrasound-assisted prostate ablation.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Profound Medical Corp. is a medical company developing minimally invasive ultrasound-based treatments for prostate cancer. This chart shows how its innovative technology, growing adoption, and competition with traditional treatments are impacting its performance in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Profound, with its prostate cancer treatment technology, is a growth story in medicine. Its stock price is driven not by the economy, but by the speed of adoption by doctors and the insurance system. The chart reflects the potential of this breakthrough technology in the vast oncology market, regardless of the economic climate.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Profound Medical Corp.
Profound Medical develops innovative ultrasound-based cancer treatments. Its monthly performance is driven by progress in commercializing its TULSA-PRO technology. News about the growing number of procedures, regulatory approvals, and clinical partnerships are the main drivers of the company's valuation.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Profound Medical develops and markets non-invasive treatment technology using MRI-guided focused ultrasound, specifically for prostate cancer. The chart below shows the overall dynamics of the therapeutic equipment sector, reflecting the demand for less invasive and more precise treatment methods.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of medical companies with breakthrough but not yet fully adopted technology are extremely volatile. The chart below shows the overall risk appetite. Does Profound Medical move at its own pace, driven by news about the application of its technology?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Profound Medical Corp.
Profound Medical's weekly performance reflects innovations in prostate cancer treatment. The company, which developed a minimally invasive ultrasound-based treatment, is responding to the pace of clinical adoption of its technology and its effectiveness.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Profound Medical develops minimally invasive treatments, including those using ultrasound. The company's success depends on the implementation of its technologies in medical practice. This chart will help separate Profound's stock performance from the broader medical equipment sector and understand the market's confidence in its unique developments.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Profound Medical develops innovative medical devices. Demand for its products is driven by medical needs. The chart below will help you determine whether PROF shares are truly a "safe haven" asset, demonstrating stability amid market uncertainty.
Market capitalization of the company, segment and market as a whole
PROF - Market capitalization of the company Profound Medical Corp.
Profound Medical's market capitalization chart tells the story of a company commercializing non-invasive ultrasound-based prostate cancer treatment. Its volatile dynamics reflect the long road to acceptance by doctors and insurance companies. This trajectory tells the story of the struggle for a new standard of treatment.
PROF - Share of the company's market capitalization Profound Medical Corp. within the market segment - Therapeutic medical equipment
Profound Medical develops and commercializes focused ultrasound-based therapeutic devices for minimally invasive treatment of diseases. Its market share reflects the potential of its technology. The chart below shows how the market perceives its chances of establishing a new standard of treatment, for example, for prostate cancer.
Market capitalization of the market segment - Therapeutic medical equipment
Profound Medical is developing a technology for minimally invasive treatment of prostate cancer and other diseases using focused ultrasound. The graph below shows the market capitalization of the medical device sector. Its growth reflects the trend toward more gentle and precise treatment methods.
Market capitalization of all companies included in a broad market index - GURU.Markets
Profound Medical is developing a technology for minimally invasive ultrasound-based treatment of prostate cancer. Its market cap reflects the company's bet that its technology will become the new standard of treatment. Its performance on the overall chart reflects how medical innovations can transform patients' lives and create new value.
Book value capitalization of the company, segment and market as a whole
PROF - Book value capitalization of the company Profound Medical Corp.
Profound Medical's balance sheet represents its capital invested in the commercialization of its unique TULSA-PRO technology for minimally invasive ultrasound treatment of prostate cancer. This is real, science-intensive capital capable of changing the standard of treatment. How has this medical technology asset evolved? The chart below shows its dynamics.
PROF - Share of the company's book capitalization Profound Medical Corp. within the market segment - Therapeutic medical equipment
Profound Medical develops technology for non-invasive treatment using focused ultrasound. The chart shows the proportion of its R&D and manufacturing assets, reflecting the physical foundation upon which this innovative medical equipment is created.
Market segment balance sheet capitalization - Therapeutic medical equipment
Profound Medical develops ultrasound-based therapeutic equipment. Creating such complex medical systems requires both R&D and manufacturing capacity. The book value chart shows the real assets behind this innovative technology.
Book value of all companies included in the broad market index - GURU.Markets
Profound Medical Corp. develops non-invasive ultrasound treatments. Its book value is represented by its manufacturing facilities for the TULSA-PRO systems, as well as its R&D centers. The chart shows the physical value of this company, whose assets are changing the approach to prostate cancer treatment.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Profound Medical Corp.
Profound Medical owns the technology, not the factories. The chart shows the huge premium the market is paying for its non-invasive ultrasound-based cancer treatment. This represents a measure of its intellectual property and potential to change surgical standards.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Profound Medical is developing a technology for minimally invasive treatment of prostate cancer and other diseases using focused ultrasound. The chart shows the market premium for this revolutionary medical technology and its potential to change treatment standards.
Market to book capitalization ratio for the market as a whole
Profound Medical develops a minimally invasive treatment for prostate cancer and other diseases using MRI-guided focused ultrasound. The company's value lies in its unique medical technology. This chart shows the overall valuation, but how does the market value a company offering an alternative to traditional surgery?
Debts of the company, segment and market as a whole
PROF - Company debts Profound Medical Corp.
Profound Medical, a company with an innovative prostate cancer treatment technology, is in the commercialization phase. Its financial strategy is focused on product promotion. Capital is being used to finance sales and marketing to convince clinics worldwide to implement its cutting-edge system.
Market segment debts - Therapeutic medical equipment
Profound Medical develops and commercializes devices for minimally invasive treatment of diseases using focused ultrasound. Bringing such complex medical equipment to market is a lengthy and expensive process. This chart shows how the company funds its clinical research and marketing.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Profound Medical Corp.
Profound Medical develops devices for minimally invasive treatment of diseases, including prostate cancer. This chart shows how the company finances its expensive research and development and regulatory approval process. For a medical device manufacturer, debt is a bridge across the "valley of death" before commercial sales.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Profound Medical develops and commercializes ultrasound-based therapeutic devices for tissue ablation. This chart shows the overall debt burden in the medical device sector. It helps assess how companies finance their expensive research and clinical trials to bring innovative technologies to market.
Debt to book value of all companies in the market
Profound Medical develops devices for minimally invasive ultrasound-based treatment. This is a medical technology sector that requires investment in R&D, clinical trials, and marketing. The market's total debt load chart helps understand whether the company is choosing equity or debt financing to bring its technology to market.
P/E of the company, segment and market as a whole
P/E - Profound Medical Corp.
This metric for Profound Medical, a company developing non-invasive treatments using focused ultrasound, demonstrates the valuation of its technology. The multiple reflects investors' belief that its method will become an alternative to surgery for diseases like prostate cancer, offering significant market potential.
P/E of the market segment - Therapeutic medical equipment
Minimally invasive surgery, where Profound Medical offers its technology, is the future of medicine. This chart shows the average rating for medical device companies. It helps us understand that Profound, with its ultrasound treatment technology, is being evaluated based on its potential to offer an alternative to traditional surgery for prostate cancer treatment.
P/E of the market as a whole
Profound Medical Corp. develops and markets therapeutic platforms for minimally invasive treatment of diseases such as prostate cancer using ultrasound. This is cutting-edge medical technology. This chart, showing the overall market "temperature," helps us understand whether Profound Medical is valued for its innovative approach or whether its valuation follows general medical tech trends.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Profound Medical Corp.
Profound Medical is developing TULSA-PRO technology for minimally invasive ultrasound-based prostate cancer treatment. This graph reflects investor expectations for the adoption of this technology in urological practice. This momentum is a bet that this method will become the standard of care.
%20P%2FE%20Profound%20Medical%20Corp.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Profound-Medical-Corp.&v=1772513436385 "Chart of the company's future (projected) P/E Profound Medical Corp.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Profound Medical is developing a non-invasive treatment technology using MRI-guided focused ultrasound. This chart shows the expected profitability of the sector, helping to understand how highly the market values the potential of this breakthrough technology for the treatment of prostate cancer and other conditions.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772513436392 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Profound Medical Corp. develops and markets minimally invasive ultrasound-based therapeutic devices for the treatment of prostate cancer and tremors. This chart reflects sentiment in the healthcare sector. For a company offering an innovative alternative to surgery and radiation therapy, it reflects the market's willingness to invest in new medical technologies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513436430 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Profound Medical Corp.
Profound Medical Corp. develops and markets minimally invasive ultrasound-based therapeutic devices for the treatment of prostate cancer and tremor. Commercial success, as demonstrated by this graph, depends on the adoption of its technology by physicians and hospitals. The dynamics reflect the medical innovator's journey from development to generating stable revenue.
Profit of companies in the market segment - Therapeutic medical equipment
Profound Medical develops and markets focused ultrasound-based therapeutic devices for the minimally invasive treatment of prostate cancer and other conditions. Its TULSA-PRO technology offers an alternative to surgery. This graph illustrates how medical innovations can change treatment standards and create a new, profitable market for companies like Profound.
Overall market profit
Profound Medical develops technology for minimally invasive treatment of prostate cancer and other diseases using focused ultrasound. The implementation of such innovative medical technologies in clinics depends on their effectiveness and cost-effectiveness. The company's growth reflects the healthcare system's willingness to invest in new treatment methods.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Profound Medical Corp.
Profound Medical develops and markets ultrasound-based therapeutic systems for minimally invasive treatment of prostate cancer and other conditions. The revenue forecast in this chart reflects analysts' expectations for the implementation of its technology in hospitals and clinics.
%20profit%20of%20the%20company%20Profound%20Medical%20Corp.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Profound-Medical-Corp.&v=1772513436545 "Graph of future (projected) profit of the company Profound Medical Corp.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Profound Medical Corp. develops and commercializes minimally invasive ultrasound-based therapeutic devices for the treatment of prostate cancer and other conditions. This chart shows the revenue forecast for the therapeutic medical device sector, helping to assess how Profound Medical's innovative technology may be adopted by the medical community.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772513436567 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Profound Medical is developing a technology for minimally invasive prostate cancer treatment. Demand for its equipment depends on hospital budgets and physician acceptance of the technology. This dynamic, reflecting the state of the economy, affects medical institutions' ability to invest in new, expensive equipment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513436578 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Profound Medical Corp.
Profound Medical is developing a minimally invasive treatment using MRI-guided focused ultrasound, primarily for prostate cancer. This chart shows how investors estimate revenue from sales of its TULSA-PRO system. This valuation is a bet on the adoption of this new technology.
P/S market segment - Therapeutic medical equipment
Profound Medical develops and commercializes focused ultrasound-based therapeutic devices for the minimally invasive treatment of prostate cancer and other conditions. This chart shows the average price-to-sales ratio for the medical device sector. It reflects how investors view the potential of this innovative technology to change treatment standards.
P/S of the market as a whole
Profound Medical develops and commercializes focused ultrasound-based therapeutic devices for the minimally invasive treatment of prostate cancer and other conditions. This market valuation chart shows how investors value medical technology companies whose innovations have the potential to change the standard of surgical treatment.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Profound Medical Corp.
Profound Medical is developing a technology for non-invasive tissue destruction using focused ultrasound, primarily for the treatment of prostate cancer. This chart shows the company's estimated future sales, reflecting investor expectations for the clinical implementation of its technology.
%20P%2FS%20Profound%20Medical%20Corp.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Profound-Medical-Corp.&v=1772513436616 "The graph of the company's future (projected) P/S Profound Medical Corp.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Profound Medical develops and commercializes therapeutic devices using focused ultrasound for the minimally invasive treatment of diseases such as prostate cancer. This chart reflects investor expectations for its innovative medical technology and its potential to change the standard of care.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772513436618 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Profound Medical develops a technology for minimally invasive treatment of prostate cancer and other diseases using focused ultrasound. The company's growth depends on the adoption of its technology. This general expectations chart for PROF is not a direct driver. Demand for its products is determined by clinical effectiveness and acceptance by the medical community.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513436629 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Profound Medical Corp.
This graph shows the commercialization of an innovative medical technology. For Profound Medical, it reflects revenue from sales of its TULSA-PRO® system, which uses ultrasound for minimally invasive treatment of prostate conditions. The trend is an indicator of the adoption of this technology in clinics.
Sales of companies in the market segment - Therapeutic medical equipment
Profound Medical Corp. is developing a minimally invasive ultrasound-based tissue ablation technology for the treatment of prostate cancer and other conditions. This chart shows revenue for the medical device sector. The clinical adoption of Profound's TULSA-PRO technology could change the standard of care and significantly increase the overall market size.
Overall market sales
Profound Medical is developing a technology for minimally invasive treatment of prostate cancer and other diseases using focused ultrasound. The introduction of its technology in hospitals reflects the trend toward more gentle and precise treatment methods. This is an indicator of innovation in the medical equipment sector, which improves patient outcomes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Profound Medical Corp.
Profound Medical is developing a non-invasive treatment for conditions such as prostate cancer using MRI-guided focused ultrasound. Future sales depend on the adoption of this cutting-edge technology in hospitals.
%20sales%20of%20the%20company%20Profound%20Medical%20Corp.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Profound-Medical-Corp.&v=1772513436671 "Schedule of future (projected) sales of the company Profound Medical Corp.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Profound Medical Corp. is developing non-invasive treatments using focused ultrasound. The forecast for the therapeutic medical device sector highlights the demand for innovation. The chart illustrates how the trend toward minimal surgical intervention is creating a market for technologies like TULSA-PRO for prostate cancer treatment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772513436675 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Profound Medical is developing a technology for minimally invasive treatment of prostate cancer and other diseases using focused ultrasound. Demand for its products depends on the acceptance of the technology by the medical community. This general economic activity affects hospital budgets and their ability to invest in new expensive equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513436685 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Profound Medical Corp.
Profound Medical develops and commercializes therapeutic devices using focused ultrasound to treat prostate cancer and tremor. Profitability depends on sales of these innovative systems. This chart shows how the company balances R&D and commercialization expenses with revenue from the implementation of its technology.
Market segment marginality - Therapeutic medical equipment
Profound Medical Corp. develops and markets technology for minimally invasive treatment of diseases using focused ultrasound. Profitability depends on sales of its system and consumables. This chart shows the operational effectiveness of this innovative therapeutic platform compared to traditional surgical methods.
Market marginality as a whole
Profound Medical Corp. develops and markets minimally invasive therapeutic devices for the treatment of prostate diseases. This chart shows the overall profit margin. In this context, Profound is a story of commercializing a breakthrough medical technology. Its path to profitability depends on the adoption of its systems in clinics and insurance reimbursement.
Employees in the company, segment and market as a whole
Number of employees in the company Profound Medical Corp.
Profound Medical is developing TULSA-PRO technology for minimally invasive prostate cancer treatment. The growth of its team, particularly in sales and clinical support, is a leading indicator of hospital adoption of this technology. This chart shows how the company is building a commercial infrastructure to advance its innovative approach.
Share of the company's employees Profound Medical Corp. within the market segment - Therapeutic medical equipment
Profound Medical develops and commercializes therapeutic devices using focused ultrasound for minimally invasive treatments, such as prostate cancer. This chart illustrates its technological specialization. It reflects the percentage of medical engineers and clinical specialists in the narrow field of therapeutic ultrasound that Profound attracts.
Number of employees in the market segment - Therapeutic medical equipment
Profound Medical is developing a technology for minimally invasive treatment of diseases using focused ultrasound. This chart illustrates breakthrough innovations in medical technology. The growing team of engineers and clinicians here signifies progress in creating an alternative to traditional surgery that could be safer and more effective.
Number of employees in the market as a whole
Profound Medical Corp. develops non-invasive ultrasound-based treatments. It's a high-tech medical company. Its growth depends on regulatory approvals and clinical implementation of its technology, not on the overall economic situation, as this chart illustrates. Successful commercialization is what drives their staffing needs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Profound Medical Corp. (PROF)
Profound Medical develops a minimally invasive treatment technology using MRI-guided focused ultrasound. This chart shows how the market values breakthrough medical technologies. Their high market capitalization per employee reflects the value of their unique platform, which could change the standard of treatment for conditions such as prostate cancer.
%20of%20the%20company%20Profound%20Medical%20Corp.%20(PROF)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Profound-Medical-Corp.-PROF&v=1772513436823 "Chart of market capitalization per employee (in thousands of dollars) of the company Profound Medical Corp. (PROF)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Profound Medical develops devices for minimally invasive treatment of diseases. It is a high-tech medical company. This chart shows how the market values its technology and patents. The high cost per employee indicates that the primary value is created by a small team of engineers and scientists in the R&D process.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772513436833 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Profound Medical develops and markets ultrasound-based therapeutic devices for the non-invasive treatment of conditions such as prostate cancer. This chart reflects the employee's high rating, as the company's innovative medical technology has the potential to change the standard of care.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513436844 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Profound Medical Corp. (PROF)
Profound Medical develops and markets devices (TULSA-PRO) for minimally invasive prostate cancer treatment using MRI-guided ultrasound. This is high-tech medical technology. This chart shows how successful its commercialization is. It measures how much profit (or loss) each engineer and salesperson generates by promoting this expensive equipment to clinics.
%20Chart%20Profound%20Medical%20Corp.%20(PROF)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Profound-Medical-Corp.-PROF&v=1772513436863 "Company Profit Per Employee (in thousands of dollars) Chart Profound Medical Corp. (PROF)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Profound Medical (PROF) is developing a technology (TULSA-PRO) for minimally invasive prostate cancer treatment. This chart sets the benchmark in the medical equipment sector. PROF's effectiveness depends on the implementation of their systems in clinics. Their model (selling equipment and consumables) means that profitability per employee will increase as the installed base of their systems grows.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772513436881 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Profound Medical (PROF) develops devices for minimally invasive treatment using TULSA-PRO technology (for prostate cancer). It is a MedTech company. Its profitability depends on the successful commercialization of its sophisticated equipment. This chart shows how successfully the R&D and sales teams are bringing this innovative technology to clinics.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513436915 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Profound Medical Corp. (PROF)
Profound Medical develops technology for non-invasive treatment using focused ultrasound. This chart shows the commercialization stage of its medical equipment. Growth in this indicator will reflect the successful implementation of its systems in clinics and the company's ability to monetize its innovations.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Profound-Medical-Corp.-PROF&v=1772513436948 "Sales chart per company employee Profound Medical Corp. (PROF)")
Sales per employee in the market segment - Therapeutic medical equipment
Profound Medical develops and markets devices (TULSA-PRO) for minimally invasive prostate cancer treatment using MRI and ultrasound. This metric reflects how productive their R&D and sales teams are generating revenue by introducing this expensive and complex technology to clinics worldwide.
Sales per employee for the market as a whole
Profound Medical develops and markets the TULSA-PRO system, which uses MRI-guided ultrasound for prostate tissue ablation. It's a high-tech medical device. This graph shows revenue per employee. It reflects the commercial success of their expensive, innovative system and the effectiveness of their sales team.
Short shares by company, segment and market as a whole
Shares shorted by company Profound Medical Corp. (PROF)
Profound Medical is developing TULSA-PRO technology, which uses MRI-guided focused ultrasound for minimally invasive prostate cancer treatment. This chart highlights bearish bets. Bears may doubt that this complex and expensive procedure will be widely adopted and compete with traditional surgery or radiation therapy.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Profound-Medical-Corp.-PROF&v=1772513436977 "Short Shares Chart for the Company Profound Medical Corp. (PROF)")
Shares shorted by market segment - Therapeutic medical equipment
Profound Medical develops medical devices for tissue ablation (destruction), specifically TULSA-PRO for prostate cancer treatment. This chart shows overall short positions in the medical equipment sector. If it's high, investors may be concerned that hospitals are cutting budgets for expensive new equipment.
Shares shorted by the overall market
Profound Medical (PROF) develops innovative (and expensive) medical equipment. This is an R&D story. When this fear indicator rises, investors anticipate a recession. They fear that hospitals, faced with budget cuts, will immediately freeze purchases of new, expensive, and "unproven" equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Profound Medical Corp. (PROF)
Profound Medical is developing the TULSA-PRO technology for the treatment of prostate cancer. Business depends on hospital adoption and reimbursement. A chart above 70 may reflect positive news about approvals or an increase in the number of procedures. A level below 30 indicates slow adoption or payment issues.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Profound-Medical-Corp.-PROF&v=1772513437015 "RSI 14 indicator chart for the company's stock Profound Medical Corp. (PROF)")
RSI 14 Market Segment - Therapeutic medical equipment
Profound (PROF) is a "robot" for *urology*. Their system (TULSA-PRO) uses *ultrasound* (HIFU) *within an MRI* for *non-invasive* prostate cancer treatment. The "Therapeutic medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps to differentiate: is PROF's growth their "TULSA niche" or a general "overheating"?
RSI 14 for the overall market
Profound Medical, a manufacturer of innovative medical equipment, sees hospital budgets in this graph. During periods of euphoria and budget growth, clinics eagerly purchase innovative, expensive equipment. During moments of panic and cost-cutting, these multi-million dollar purchases are postponed indefinitely.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PROF (Profound Medical Corp.)
Profound Medical is developing TULSA-PRO technology. This minimally invasive procedure uses MRI and ultrasound to ablate prostate tissue (a cancer treatment). This chart shows the analysts' average 12-month forecast, reflecting their bet on how quickly this technology will be adopted.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PROF-Profound-Medical-Corp.&v=1772513437058 "A chart showing analyst consensus forecasts for the expected stock price. PROF (Profound Medical Corp.)")
The difference between the consensus estimate and the actual stock price PROF (Profound Medical Corp.)
Profound Medical (PROF) is a medical technology company that developed TULSA, a non-invasive MRI- and ultrasound-based procedure for treating prostate cancer. This chart shows their R&D estimates. It measures the gap between the price and the consensus target, reflecting whether analysts believe their technology will be widely adopted by urologists and hospitals.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PROF-Profound-Medical-Corp.&v=1772513437078 "A chart showing the difference between the consensus forecast and the actual stock price. PROF (Profound Medical Corp.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Profound Medical is the medical company that developed TULSA-PRO, a robotic system that uses MRI and ultrasound to "burn" prostate cancer without incisions. This chart shows general expectations for the therapeutic medical equipment sector. It reflects whether experts believe the non-invasive surgery market will grow.
Analysts' consensus forecast for the overall market share price
Profound Medical develops minimally invasive treatments, specifically using focused ultrasound (TULSA-PRO) for prostate tissue ablation. This chart shows overall market sentiment. For Profound, a company with an expensive and innovative medical technology, the overall optimism is important because it reflects hospitals' willingness to invest in new equipment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Profound Medical Corp.
Profound Medical is a MedTech company that sees and treats. Their flagship platform (TULSA-PRO) uses MRI-guided intraurethral ultrasound (HIFU) for prostate cancer treatment while sparing healthy tissue. This chart is a summary of their razor and blade portfolio. It reflects their ability to sell high-end razors (devices) and their growing blade revenue (disposables).
AKIMA Market Segment Index - Therapeutic medical equipment
Profound Medical is developing TULSA-PRO technology, a minimally invasive MRI-based procedure that uses ultrasound to ablate prostate tissue. This graph shows the average index for the therapeutic equipment sector. It allows one to assess how far Profound Medical's innovative technology outperforms the industry average.
The AKIM Index for the overall market
Profound Medical is a MedTech company commercializing the TULSA system for non-surgical, MRI-guided prostate tissue ablation. This chart, reflecting the market average, provides context. It helps assess how this paradigm-shifting technology compares to overall macroeconomic trends and urological adoption.
